2018

adalimumab

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2018

darbepoetin alfa

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration